Home/Filings/4/0001246360-18-001074
4//SEC Filing

Swan Winifred L 4

Accession 0001246360-18-001074

CIK 0001333170other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:28 PM ET

Size

10.2 KB

Accession

0001246360-18-001074

Insider Transaction Report

Form 4
Period: 2018-03-09
Swan Winifred L
SVP and General Counsel
Transactions
  • Award

    Restricted Stock Unit

    2018-03-09+13,97113,971 total
    Exercise: $0.00From: 2018-03-09Exp: 2020-03-09Common Stock (13,971 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2018-03-094,6579,314 total
    Exercise: $0.00From: 2018-03-09Exp: 2020-03-09Common Stock (4,657 underlying)
  • Exercise/Conversion

    Common Stock

    2018-03-09+4,65714,427 total
  • Tax Payment

    Common Stock

    2018-03-09$24.37/sh1,350$32,90013,077 total
Footnotes (1)
  • [F1]Award granted pursuant to the 2017 Performance Share Plan, vesting in 3 equal annual installments beginning March 9, 2018.

Issuer

NxStage Medical, Inc.

CIK 0001333170

Entity typeother

Related Parties

1
  • filerCIK 0001341405

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:28 PM ET
Size
10.2 KB